A two-phase epigenome-wide four-way gene–smoking interaction study of overall survival for early-stage non-small cell lung cancer
(2025) In Molecular Oncology 19(1). p.173-187- Abstract
High-order interactions associated with non-small cell lung cancer (NSCLC) survival may elucidate underlying molecular mechanisms and identify potential therapeutic targets. Our previous work has identified a three-way interaction among pack-year of smoking (the number of packs of cigarettes smoked per day multiplied by the number of years the person has smoked) and two DNA methylation probes (cg05293407TRIM27 and cg00060500KIAA0226). However, whether a four-way interaction exists remains unclear. Therefore, we adopted a two-phase design to identify the four-way gene–smoking interactions by a hill-climbing strategy on the basis of the previously detected three-way interaction. One CpG probe,... (More)
High-order interactions associated with non-small cell lung cancer (NSCLC) survival may elucidate underlying molecular mechanisms and identify potential therapeutic targets. Our previous work has identified a three-way interaction among pack-year of smoking (the number of packs of cigarettes smoked per day multiplied by the number of years the person has smoked) and two DNA methylation probes (cg05293407TRIM27 and cg00060500KIAA0226). However, whether a four-way interaction exists remains unclear. Therefore, we adopted a two-phase design to identify the four-way gene–smoking interactions by a hill-climbing strategy on the basis of the previously detected three-way interaction. One CpG probe, cg16658473SHISA9, was identified with FDR-q ≤ 0.05 in the discovery phase and P ≤ 0.05 in the validation phase. Meanwhile, the four-way interaction improved the discrimination ability for the prognostic prediction model, as indicated by the area under the receiver operating characteristic curve (AUC) for both 3- and 5-year survival. In summary, we identified a four-way interaction associated with NSCLC survival among pack-year of smoking, cg05293407TRIM27, cg00060500KIAA0226 and g16658473SHISA9, providing novel insights into the complex mechanisms underlying NSCLC progression.
(Less)
- author
- organization
- publishing date
- 2025-01
- type
- Contribution to journal
- publication status
- published
- subject
- keywords
- epigenomics, four-way interaction, gene–smoking interaction, NSCLC
- in
- Molecular Oncology
- volume
- 19
- issue
- 1
- pages
- 15 pages
- publisher
- John Wiley & Sons Inc.
- external identifiers
-
- scopus:85211088542
- pmid:39630602
- ISSN
- 1574-7891
- DOI
- 10.1002/1878-0261.13766
- language
- English
- LU publication?
- yes
- id
- 073ad71c-cccb-4517-ac97-95a91a79b985
- date added to LUP
- 2025-01-31 15:48:19
- date last changed
- 2025-06-07 01:31:48
@article{073ad71c-cccb-4517-ac97-95a91a79b985, abstract = {{<p>High-order interactions associated with non-small cell lung cancer (NSCLC) survival may elucidate underlying molecular mechanisms and identify potential therapeutic targets. Our previous work has identified a three-way interaction among pack-year of smoking (the number of packs of cigarettes smoked per day multiplied by the number of years the person has smoked) and two DNA methylation probes (cg05293407<sub>TRIM27</sub> and cg00060500<sub>KIAA0226</sub>). However, whether a four-way interaction exists remains unclear. Therefore, we adopted a two-phase design to identify the four-way gene–smoking interactions by a hill-climbing strategy on the basis of the previously detected three-way interaction. One CpG probe, cg16658473<sub>SHISA9</sub>, was identified with FDR-q ≤ 0.05 in the discovery phase and P ≤ 0.05 in the validation phase. Meanwhile, the four-way interaction improved the discrimination ability for the prognostic prediction model, as indicated by the area under the receiver operating characteristic curve (AUC) for both 3- and 5-year survival. In summary, we identified a four-way interaction associated with NSCLC survival among pack-year of smoking, cg05293407<sub>TRIM27</sub>, cg00060500<sub>KIAA0226</sub> and g16658473<sub>SHISA9</sub>, providing novel insights into the complex mechanisms underlying NSCLC progression.</p>}}, author = {{Chen, Leyi and Wang, Xiang and Xie, Ning and Zhang, Zhongwen and Xu, Xiaowen and Xue, Maojie and Yang, Yuqing and Liu, Liya and Su, Li and Bjaanæs, Maria and Karlsson, Anna and Planck, Maria and Staaf, Johan and Helland, Åslaug and Esteller, Manel and Christiani, David C. and Chen, Feng and Zhang, Ruyang}}, issn = {{1574-7891}}, keywords = {{epigenomics; four-way interaction; gene–smoking interaction; NSCLC}}, language = {{eng}}, number = {{1}}, pages = {{173--187}}, publisher = {{John Wiley & Sons Inc.}}, series = {{Molecular Oncology}}, title = {{A two-phase epigenome-wide four-way gene–smoking interaction study of overall survival for early-stage non-small cell lung cancer}}, url = {{http://dx.doi.org/10.1002/1878-0261.13766}}, doi = {{10.1002/1878-0261.13766}}, volume = {{19}}, year = {{2025}}, }